#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Teclistamab drug combination versus daratumumab and lenalidomide in MRD‑positive multiple myeloma patients after stem cell transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • Reduced vs Standard Dose Belantamab Mafodotin with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: A Phase II MRD‑Guided Study

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland

  • A study of belantamab mafodotin and mezigdomide in patients with relapsed multiple myeloma who have previously received CAR-T cell therapy or bispecific antibodies

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Melflufen and Dexamethasone for Elderly Patients with Relapsed Multiple Myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Treating Smoldering and Active Multiple Myeloma with Dexamethasone, Lenalidomide, and Carfilzomib for Patients in Iceland

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Iceland

  • Study of ixazomib, iberdomide and dexamethasone combination in elderly patients with first relapse of multiple myeloma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France

  • Study on Heparin Sodium and Sodium Chloride for Patients with Lymphoma or Myeloma Undergoing Stem Cell Collection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study on Alnuctamab and Mezigdomide for Patients with Relapsed or Refractory Multiple Myeloma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Patients with Multiple Myeloma and Acute Kidney Failure

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Austria